No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / administration & dosage
-
Adrenergic beta-Antagonists / adverse effects*
-
Cardiovascular Diseases / etiology*
-
Cardiovascular Diseases / mortality
-
Cardiovascular Diseases / prevention & control
-
Clinical Trials as Topic
-
Europe
-
Heart Rate / drug effects*
-
Humans
-
Hypertension / complications
-
Hypertension / drug therapy*
-
Hypertension / mortality
-
Risk Assessment
-
Societies, Medical
-
Sweden
-
Treatment Failure
-
United Kingdom
Substances
-
Adrenergic beta-Antagonists